Rigel Pharmaceuticals Competitors, Revenue, Alternatives and Pricing
Overview
Estimated Revenue & Financials
- Rigel Pharmaceuticals's estimated annual revenue is currently $46.8M per year.
- Rigel Pharmaceuticals received $71.8M in venture funding in April 2018.
- Rigel Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Rigel Pharmaceuticals has 302 Employees.
- Rigel Pharmaceuticals grew their employee count by 4% last year.
- Rigel Pharmaceuticals currently has 4 job openings.
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Online Review | Pricing |
---|---|---|---|---|---|---|
Advertise Here | ||||||
#1 | $7M | 45 | 10% | N/A | - | N/A |
#2 | N/A | 205 | N/A | N/A | - | N/A |
#3 | $46.8M | 302 | 4% | N/A | - | N/A |
#4 | $22.3M | 144 | N/A | N/A | - | N/A |
#5 | $44.3M | 286 | N/A | N/A | - | N/A |
#6 | $101.2M | 653 | 46% | N/A | - | N/A |
#7 | $18.6M | 120 | N/A | N/A | - | N/A |
#8 | $23.3M | 150 | N/A | N/A | - | N/A |
#9 | $33.3M | 215 | 3% | N/A | - | N/A |
#10 | $28.7M | 185 | 8% | N/A | - | N/A |
What Is Rigel Pharmaceuticals?
Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power302
Number of Employees
$46.8M
Revenue (est)
4
Current Jobs
4%
Employee Growth %
N/A
Total Funding
N/A
Valuation
N/A
Accelerator
B2B
Type
Rigel Pharmaceuticals News
Each buying and selling session display one-of-a-kind actions and patterns about Rigel Pharmaceuticals, Inc. RIGL), Biotechnology stock.
With the previous 100-day trading volume average of 1.32 million shares, Rigel Pharmaceuticals (RIGL) recorded a trading volume of 1.56 ...
Acadian Asset Management LLC boosted its position in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) by 548.3% in the second ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding | Online Review | Pricing |
---|---|---|---|---|---|---|
#1 | $54.7M | 304 | N/A | N/A | - | N/A |
#2 | $83.7M | 310 | 12% | $541M | - | N/A |
#3 | $47.3M | 326 | 4% | N/A | - | N/A |
#4 | $33.6M | 326 | 33% | $114.4M | - | N/A |
#5 | N/A | 344 | N/A | N/A | - | N/A |
Rigel Pharmaceuticals Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2002-01-18 | $31.5M | Public Offering | Article | |
2003-05-01 | $46.0M | Lead Investor: MPM C | Article | |
2003-06-30 | $46.0M | Common Stock | MPM Capital | Article |
2003-08-04 | $9.3M | Rights Offering | Article | |
2009-09-19 | $108.3M | Undisclosed | Credit Suisse Securities (USA) | Article |
2011-05-26 | $Undisclosed | Undisclosed | Jefferies & Company Inc, J P Morgan Securities LLC | Article |
2012-10-04 | $130.0M | Undisclosed | Jefferies & Company Inc, J P Morgan Securities LLC | Article |
2017-02-01 | $40.0M | Undisclosed | Jefferies LLC | Article |
2017-10-04 | $46.0M | Undisclosed | Jefferies LLC | Article |
2017-10-05 | $69.7M | Undisclosed | BMO Capital Markets Corp | Article |
2018-04-20 | $71.8M | Undisclosed | Jefferies LLC | Article |
Rigel Pharmaceuticals Executive Hires
Date | Name | Title | Reference |
---|---|---|---|
2002-10-31 | Susan Scher | VP Strategic Relations | Article |
2003-10-08 | Robin Cooper | SVP Pharmaceutical Sciences | Article |
2004-06-17 | Raul Rodriguez | COO | Article |
2006-06-07 | Ryan D. Maynard | VP Finance/CFO | Article |
2008-02-27 | Daniel B. Magilavy | VP Clinical Research | Article |
2010-06-02 | Raul Rodriguez | President/COO | Article |
2014-11-25 | Raul Rodriguez | President/COO/CEO | Article |
2016-03-09 | Anne-Marie Duliege | chief medical officer | Article |
2016-09-16 | Eldon C. Mayer | EVP/Chief commercial officer | Article |
2016-10-10 | Esteban Masuda | SVP Research | Article |
2017-12-18 | Nelson Cabatuan | interim principal accounting officer | Article |
2018-05-31 | Dean Schorno | EVP/CFO | Article |
Rigel Pharmaceuticals Staff Cuts
Date | Number of Employees | Location | Reference |
---|---|---|---|
2009-02-04 | 20 % of Staff | Article | |
2016-09-16 | 46 | Article |